Drug & medication recalls Moderate risk

PHENYLephrine HCl 1 recalled over sterility concerns

Recall date
September 12, 2019
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
KRS Global Biotechnology, Inc recalls PHENYLephrine HCl 1.5% (15 mg/mL) LIDOcaine 1% (10 mg/mL) (PF) (Sulfite Free) Ophthalmic Injection, 3 mL fill in a 5 mL…
Recall number
D-0085-2020
FDA classification
Class II
Brand / firm
KRS Global Biotechnology, Inc
Sold / distributed
Nationwide

Why it was recalled

Lack of Assurance of Sterility

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

PHENYLephrine HCl 1.5% (15 mg/mL) LIDOcaine 1% (10 mg/mL) (PF) (Sulfite Free) Ophthalmic Injection, 3 mL fill in a 5 mL Single Dose Syringe, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678170

Get recall alerts

Free email alert whenever KRS Global Biotechnology, Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: KRS Global Biotechnology, Inc